{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:40:14Z","timestamp":1733064014644,"version":"3.30.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1523,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1002\/hep.24353","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T10:05:28Z","timestamp":1309169128000},"page":"354-358","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Anti-chemokine therapy for the treatment of hepatic fibrosis: An attractive approach"],"prefix":"10.1097","volume":"54","author":[{"given":"Grant A.","family":"Ramm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Kowdley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"McCaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-38-20241201","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/17474124.2.2.233","article-title":"Chemokine-directed immune cell infiltration in acute and chronic liver disease.","volume":"2","author":"Karlmark","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R2-38-20241201","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/hep.23338","article-title":"Chemokine (C-C motif) receptors in fibrogenesis and hepatic regeneration following acute and chronic liver disease.","volume":"50","author":"Ramm","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R3-38-20241201","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1172\/JCI41732","article-title":"Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.","volume":"120","author":"Berres","year":"2010","journal-title":"J Clin Invest"},{"key":"R4-38-20241201","doi-asserted-by":"crossref","first-page":"10002","DOI":"10.1073\/pnas.142313799","article-title":"Modulating influence on HIVAIDS by interacting RANTES gene variants.","volume":"99","author":"An","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-38-20241201","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice.","volume":"119","author":"Seki","year":"2009","journal-title":"J Clin Invest"},{"key":"R6-38-20241201","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1074\/jbc.271.5.2599","article-title":"Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist.","volume":"271","author":"Proudfoot","year":"1996","journal-title":"J Biol Chem"},{"key":"R7-38-20241201","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.4049\/jimmunol.171.10.5498","article-title":"Inhibition of airway inflammation by amino-terminally modified RANTESCC chemokine ligand 5 analogues is not mediated through CCR3.","volume":"171","author":"Chvatchko","year":"2003","journal-title":"J Immunol"},{"key":"R8-38-20241201","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/hep.22597","article-title":"Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury.","volume":"49","author":"Ruddell","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R9-38-20241201","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1159\/000254389","article-title":"Questions about chemokine and chemokine receptor antagonism in renal inflammation.","volume":"114","author":"Anders","year":"2010","journal-title":"Nephron Exp Nephrol"},{"key":"R10-38-20241201","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1074\/jbc.M010750200","article-title":"Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells.","volume":"276","author":"Wong","year":"2001","journal-title":"J Biol Chem"},{"key":"R11-38-20241201","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/sj.bjp.0707691","article-title":"Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells.","volume":"153","author":"Longden","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R12-38-20241201","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.RES.0000109793.17591.4E","article-title":"Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.","volume":"94","author":"Veillard","year":"2004","journal-title":"Circ Res"},{"key":"R13-38-20241201","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm.1898","article-title":"Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice.","volume":"15","author":"Koenen","year":"2009","journal-title":"Nat Med"},{"key":"R14-38-20241201","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm1303","article-title":"CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection.","volume":"11","author":"Tyner","year":"2005","journal-title":"Nat Med"},{"key":"R15-38-20241201","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/clim.2001.5178","article-title":"Impaired T cell function in RANTES-deficient mice.","volume":"102","author":"Makino","year":"2002","journal-title":"Clin Immunol"},{"key":"R16-38-20241201","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2353\/ajpath.2007.060690","article-title":"CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis.","volume":"170","author":"Ajuebor","year":"2007","journal-title":"Am J Pathol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24353","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201107000-00038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:01:42Z","timestamp":1733061702000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201107000-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24353","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}